Market Data
ARENA: ARENA BİLGİSAYAR SANAYİ VE TİCARET A.Ş. Stock Live Price Graph
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| Jul 13, 2025 | TRY 0 | TRY 0 | 0% | TRY 0 |
| Apr 13, 2025 | TRY 0 | TRY 0 | 0% | TRY 0 |
| Mar 20, 2024 | TRY 0 | TRY 0 | 0% | TRY 0 |
Splits & capital actions
| Date | Ratio | Bonus % | Rights % | Dividend % |
|---|---|---|---|---|
| May 24, 2023 | 1.00776 | 0% | 0% | 10.37288% |
| Jun 2, 2022 | 1.01935 | 0% | 0% | 25.735% |
| Jul 1, 2021 | 3.125 | 212.5% | 0% | 0% |
| Apr 14, 2021 | 1.0097 | 0% | 0% | 50.513% |
| Apr 9, 2020 | 1.03363 | 0% | 0% | 37.744% |
| Apr 6, 2017 | 1.02581 | 0% | 0% | 11.097% |
| Apr 3, 2016 | 1.01816 | 0% | 0% | 9.667% |
| Mar 31, 2015 | 1.04335 | 0% | 0% | 15.38% |
| Apr 6, 2014 | 1.05357 | 0% | 0% | 11.93% |
| May 27, 2013 | 1.03896 | 0% | 0% | 12.27% |
| May 28, 2012 | 1.03556 | 0% | 0% | 7.91% |
| Apr 27, 2011 | 1.06164 | 0% | 0% | 18.01% |
| Apr 21, 2010 | 1.08571 | 0% | 0% | 20.78% |
| Jul 1, 2009 | 1.99231 | 100% | 0% | 0% |
| May 28, 2008 | 1.0888 | 0% | 0% | 23.02% |
| May 22, 2007 | 1.06627 | 0% | 0% | 21.37% |
| May 22, 2006 | 1.04308 | 0% | 0% | 19.08% |
| May 30, 2005 | 8.625 | 700% | 0% | 158% |
| May 28, 2003 | 1.04267 | 0% | 0% | 32.5% |
What Is ARENA? Live ARENA Prices and Analysis
ARENA Pharmaceuticals, Inc. (ARENA) is a biopharmaceutical company focused on developing innovative therapies for various diseases, particularly those related to inflammation and immunology. The company is known for its advanced drug development programs and commitment to addressing unmet medical needs. Investors closely monitor ARENA due to its potential for significant returns driven by advancements in its clinical trials and product pipeline.
The importance of ARENA in the healthcare sector cannot be overstated; its research and development efforts have the potential to transform treatment paradigms for chronic conditions. The company’s stock price is influenced by factors such as clinical trial results, regulatory approvals, and overall market sentiment, making it a point of interest for investors and analysts alike.
Market Context
ARENA operates in the biopharmaceutical sector, a critical part of the global healthcare market. This sector is characterized by high volatility, driven by the nature of drug development and approval processes. The pricing of ARENA's stock is primarily conducted in U.S. dollars, and investors should be aware of the broader economic conditions that can impact market sentiment, such as interest rates, healthcare policies, and global health crises.
Why Do ARENA Prices Rise or Fall?
The stock price of ARENA can fluctuate based on a variety of factors, which are crucial for investors to understand. These factors can range from company-specific news to broader market trends.
- Clinical trial results: Positive or negative outcomes can dramatically impact stock prices.
- Regulatory approvals: News regarding FDA approvals or rejections can lead to significant price movements.
- Partnerships and collaborations: New deals with other biopharmaceutical companies may enhance market confidence.
- Market sentiment: Overall investor sentiment towards the biopharmaceutical sector can affect ARENA's stock.
- Earnings reports: Quarterly earnings can influence investor perceptions and stock valuations.
- Dividends: Any announcements regarding dividends can affect investor interest and stock performance.
- Competition: The emergence of competing products can impact market share and pricing strategies.
- Economic indicators: Broader economic conditions can influence investor behavior and stock performance.
Understanding these factors can help investors make informed decisions about buying or selling ARENA stock. The interplay of these elements contributes to the overall volatility and potential growth of the stock.
Why Is Live ARENA Price Tracking Important?
Tracking the live price of ARENA is essential for investors for several reasons:
- Real-time information: Investors can make timely decisions based on current market conditions.
- Market trends: Observing price movements can help identify emerging trends in the biopharmaceutical sector.
- Investment strategy: Live price data aids in the development of effective trading strategies.
- Risk management: Monitoring price changes helps investors manage their risk exposure effectively.
- Sentiment analysis: Live tracking can provide insights into market sentiment around ARENA.
What Should You Consider When Trading / Investing in ARENA?
Investing in ARENA carries certain risks and considerations that potential investors should be aware of:
- Volatility: ARENA's stock can be highly volatile, especially around clinical trial announcements.
- Regulatory risk: Changes in regulations or unexpected FDA decisions can impact stock performance.
- Market conditions: Broader economic factors can influence investor sentiment and stock prices.
- Financial health: Investors should analyze the company's financial statements, including earnings and cash flow.
- Long-term potential: Assess the long-term viability of ARENA’s product pipeline and market strategies.
What Can You Find on the Investvio ARENA Page?
- Live price updates and historical data.
- Comprehensive charts for technical analysis.
- Latest news and developments related to ARENA.
- Earnings reports and dividend announcements.
- Expert analysis and market sentiment insights.
The Investvio ARENA page provides a wealth of information that can help investors stay informed and make strategic decisions regarding their investments in ARENA Pharmaceuticals. By leveraging this information, investors can better navigate the complexities of the biopharmaceutical market.